Brian E. Weinrich

Array ( [id] => 3065208 [patent_doc_number] => 05310875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Peptides corresponding to membrane-bound IgA' [patent_app_type] => 1 [patent_app_number] => 8/055917 [patent_app_country] => US [patent_app_date] => 1993-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6991 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310875.pdf [firstpage_image] =>[orig_patent_app_number] => 055917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3035131 [patent_doc_number] => 05328997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-12 [patent_title] => 'Processes for making proteins having anticoagulant properties' [patent_app_type] => 1 [patent_app_number] => 8/054761 [patent_app_country] => US [patent_app_date] => 1993-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 12177 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/328/05328997.pdf [firstpage_image] =>[orig_patent_app_number] => 054761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521436 [patent_doc_number] => 05530109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'DNA encoding glial mitogenic factors' [patent_app_type] => 1 [patent_app_number] => 8/036555 [patent_app_country] => US [patent_app_date] => 1993-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 89 [patent_no_of_words] => 35895 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/530/05530109.pdf [firstpage_image] =>[orig_patent_app_number] => 036555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3020329 [patent_doc_number] => 05302702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-12 [patent_title] => 'Chimeric fibroblast growth factors' [patent_app_type] => 1 [patent_app_number] => 8/023757 [patent_app_country] => US [patent_app_date] => 1993-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7558 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/302/05302702.pdf [firstpage_image] =>[orig_patent_app_number] => 023757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3065090 [patent_doc_number] => 05294569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-15 [patent_title] => 'Endothelin DNA and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/009764 [patent_app_country] => US [patent_app_date] => 1993-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6247 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/294/05294569.pdf [firstpage_image] =>[orig_patent_app_number] => 009764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3446994 [patent_doc_number] => 05420243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-30 [patent_title] => 'Biologically active TGF-.beta.2 peptides' [patent_app_type] => 1 [patent_app_number] => 8/009448 [patent_app_country] => US [patent_app_date] => 1993-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6954 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/420/05420243.pdf [firstpage_image] =>[orig_patent_app_number] => 009448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3073807 [patent_doc_number] => 05360896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-01 [patent_title] => 'Glycosylated FGF' [patent_app_type] => 1 [patent_app_number] => 8/007089 [patent_app_country] => US [patent_app_date] => 1993-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 10836 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/360/05360896.pdf [firstpage_image] =>[orig_patent_app_number] => 007089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2999329 [patent_doc_number] => 05359032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Interkeukin-1 inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/985506 [patent_app_country] => US [patent_app_date] => 1992-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 7896 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/359/05359032.pdf [firstpage_image] =>[orig_patent_app_number] => 985506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3029932 [patent_doc_number] => 05349056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-20 [patent_title] => 'Modified ciliary neurotrophic factors' [patent_app_type] => 1 [patent_app_number] => 7/959284 [patent_app_country] => US [patent_app_date] => 1992-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5747 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/349/05349056.pdf [firstpage_image] =>[orig_patent_app_number] => 959284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471651 [patent_doc_number] => 05427780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Composition comprising Mullerian inhibiting substance-like polypeptides' [patent_app_type] => 1 [patent_app_number] => 7/957061 [patent_app_country] => US [patent_app_date] => 1992-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10574 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/427/05427780.pdf [firstpage_image] =>[orig_patent_app_number] => 957061 [rel_patent_id] =>[rel_patent_doc_number] =>)